Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

KGI's Jeniffer Hernandez and Animesh Ray Selected As 2021 NIH Director's Transformative Research Award Recipients

KGI Professors Dr. Jeniffer Hernandez and Dr. Animesh Ray have been selected as 2021 National Institutes of Health (NIH) Director's Transformative Research Award recipients as part of the NIH Common Fund's High-Risk, High-Reward Research program.


News provided by

Keck Graduate Institute (KGI)

Oct 05, 2021, 20:45 ET

Share this article

Share toX

Share this article

Share toX

KGI's Jeniffer Hernandez and Animesh Ray have been selected as 2021 National Institutes of Health (NIH) Director’s Transformative Research Award recipients.
KGI's Jeniffer Hernandez and Animesh Ray have been selected as 2021 National Institutes of Health (NIH) Director’s Transformative Research Award recipients.

CLAREMONT, Calif., Oct. 5, 2021 /PRNewswire-PRWeb/ -- Keck Graduate Institute (KGI) Associate Professor of Biopharmaceutical Sciences Dr. Jeniffer Hernandez and Professor Dr. Animesh Ray have been selected as 2021 National Institutes of Health (NIH) Director's Transformative Research Award recipients as part of the NIH Common Fund's High-Risk, High-Reward Research program. This fund supports inherently risky and untested projects that can potentially create or overturn fundamental science, technology, and medicine paradigms.

For the project, the team is developing a computer assessment procedure for predicting the structure of antibodies that could effectively neutralize a previously unknown antigen or a novel virus that might emerge in the future. These findings could have a tremendous impact on any emerging pandemic.

For the project, the team is developing a computer assessment procedure for predicting the structure of antibodies that could effectively neutralize a previously unknown antigen or a novel virus that might emerge in the future. These findings could have a tremendous impact on any emerging pandemic.

Post this

The project is a multi-disciplinary collaboration between Hernandez, Ray, and two other Consortium Principal Investigators: Dr. Stefano Lonardi from UC Riverside's Department of Computer Science, a respected computer scientist who works with machine learning and biological data; and Dr. Matthew Sazinsky from Pomona College's Department of Chemistry, a protein biochemist trained in the physics of high molecular weight polymers.

In addition to vaccine development, the research project could influence medicine on a broader scale. For example, antibodies could potentially be predicted in a computer to target and neutralize proteins made by cancer cells. Another potential use would be therapies that help patients to manage their allergies and hypersensitivity issues.

This five-year project builds upon research Ray has been conducting for the past 13 years on machine learning methods to predict novel protein-protein interactions.

"Intrinsically, this kind of deep machine learning involves a competitive game between some of the real data that it learns from achieving a task and random data that the deep learning algorithm makes by itself to foil that attempt," Ray said. "Ultimately, we want the game based on real data to succeed."

This concept is similar in principle to evolution, where random genetic variations emerge and compete with one another. Those variations best suited for survival in an organism's natural environment win out and are passed down to the next generation.

Another goal of the project is to use single-cell DNA sequencing of the antibody genetic repertoire naturally raised against an injected antigen to produce a large amount of data quickly. Subsequent benchmarks will quantitatively evaluate the best performing computational model to predict a strong binding antibody and then fine-tune that to make a neutralizing antibody which one can quickly test in a laboratory.

Monoclonal antibody therapies for COVID-19, which the FDA gave emergency authorization, were developed with unprecedented speed. At the time that therapies for COVID were being developed, they still needed three months of lead time to go from the viral protein structure to that of the monoclonal antibody. Ray, Hernandez, and the team thought that if they could do that particular step in a computer in a few hours, they estimated that they could probably have started the clinical trial in March instead of July, saving thousands of lives. That is the transformative impact of the potential outcomes of this project.

This project, co-led by Ray, Hernandez, Lonardi, and Sazinksy, was among 19 Transformative Research Awards made this year by NIH.

"The science put forward by this cohort is exceptionally novel and creative and is sure to push at the boundaries of what is known," said NIH Director Francis S. Collins, MD, PhD. "These visionary investigators come from a wide breadth of career stages and show that groundbreaking science can happen at any career level given the right opportunity."

---

The research project was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01Al169543. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Media Contact

Lauren Porta, Keck Graduate Institute (KGI), 9096070931, [email protected]

SOURCE Keck Graduate Institute (KGI)

Related Links

http://kgi.edu

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.